Getinge AB Class B GETI B
Trading Information
- Previous Close Price
- SEK 215.70
- Day Range
- SEK 214.70–217.30
- 52-Week Range
- SEK 174.85–240.20
- Bid/Ask
- SEK 215.20 / SEK 215.40
- Market Cap
- SEK 58.64 Bil
- Volume/Avg
- 245,938 / 661,144
Key Statistics
- Price/Earnings (Normalized)
- 21.66
- Price/Sales
- 1.76
- Dividend Yield (Trailing)
- 2.04%
- Dividend Yield (Forward)
- 2.04%
- Total Yield
- 2.04%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,891
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GETI B
|
SYK
|
TFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.66 | 31.28 | 17.52 |
Price/Book Value | 1.87 | 6.77 | 2.47 |
Price/Sales | 1.76 | 6.31 | 3.76 |
Price/Cash Flow | 11.32 | 29.81 | 17.72 |
Price/Earnings
GETI B
SYK
TFX
Financial Strength
|
Metric
|
GETI B
|
SYK
|
TFX
|
|---|---|---|---|
Quick Ratio | 0.65 | 0.81 | 1.23 |
Current Ratio | 1.15 | 1.68 | 2.58 |
Interest Coverage | 9.07 | 12.28 | 3.88 |
Quick Ratio
GETI B
SYK
TFX
Profitability
|
Metric
|
GETI B
|
SYK
|
TFX
|
|---|---|---|---|
Return on Assets (Normalized) | 5.02% | 11.13% | 6.62% |
Return on Equity (Normalized) | 8.70% | 23.26% | 11.06% |
Return on Invested Capital (Normalized) | 7.75% | 14.77% | 8.92% |
Return on Assets
GETI B
SYK
TFX
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Mfxmsjqw | Vyrgjp | $196.0 Bil | |||
| Stryker Corp
SYK
| Pxkphkxwz | Cfzc | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Nzxbnhcd | Skgblm | $124.5 Bil | |||
| Medtronic PLC
MDT
| Pdsltfsq | Qxggrdz | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Bqrylwcgp | Rjkdfx | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Byfrx | Byl | $30.1 Bil | |||
| DexCom Inc
DXCM
| Cfpvfzwj | Cqpm | $27.3 Bil | |||
| Steris PLC
STE
| Cyfnxvp | Bnfdyml | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Jlgpmpmytl | Jsbb | $21.3 Bil | |||
| Insulet Corp
PODD
| Jdmtylcq | Yvrgcz | $16.1 Bil |
United States